Mass spectrometry MALDI imaging of colon cancer biomarkers: a new diagnostic paradigm

被引：23

作者：

Pevsner, Paul H. ^{[1
]}

Melamed, Jonathan ^{[2
]}

Remsen, Tiffany ^{[1
]}

Kogos, Alexander ^{[1
]}

Francois, Fritz ^{[3
]}

Kessler, Paul ^{[1
]}

Stern, Arnold ^{[1
]}

Anand, Sury ^{[4
]}

机构：

[1] NYU, Sch Med, Dept Pharmacol, New York, NY 10003 USA

[2] NYU, Sch Med, Dept Pathol, New York, NY USA

[3] NYU, Sch Med, Dept Med, Div Gastroenterol, New York, NY USA

[4] Brooklyn Hosp Ctr, Div Gastroenterol, Dept Pharmacol, Brooklyn, NY USA

来源：

BIOMARKERS IN MEDICINE | 2009年 / 3卷 / 01期

关键词：

biomarker; colorectal cancer; imaging; LCMS; liquid chromatography mass spectrometry; MALDI IMS; mass spectrometry; matrix-assisted laser desorption/ionization imaging mass spectrometry; HUMAN CHORIONIC-GONADOTROPIN; DIRECT TISSUE-ANALYSIS; COLORECTAL-CANCER; APOPTOSIS; PROTEINS; MUCOSA; EXPRESSION; CELLS; MS; IDENTIFICATION;

D O I：

10.2217/17520363.3.1.55

中图分类号：

R-3 [医学研究方法]; R3 [基础医学];

学科分类号：

1001 ;

摘要：

Colorectal cancer (CRC), is the second-leading cause of cancer-related deaths in the USA, affecting both men and women. Current projections show little or no change since the publication of a morbidity and mortality study in 2005. The projected number of new cases for 2008 is 154,000, and the projected number of CRC cancer deaths for 2008 is 53,000. The standard diagnostic paradigm is based on histopathology of either biopsy or surgical specimens. This article suggests a new paradigm for colon cancer diagnosis and staging using matrix-assisted laser desorption/ionization imaging mass spectrometry (MALDI IMS or IMS). IMS may identify potential tumors in normal tissue of cancer patients and predict those cancer patients who are at risk for recurrent cancer.

引用

页码：55 / 69

页数：15

共 50 条

[21] MALDI imaging mass spectrometry: an emerging tool in neurology
Laura K. Schnackenberg
David A. Thorn
Dustyn Barnette
E. Ellen Jones
Metabolic Brain Disease, 2022, 37 : 105 - 121
[22] Stretched Tissue Mounting for MALDI Mass Spectrometry Imaging
Tucker, Kevin R.
Lanni, Eric J.
Serebryannyy, Leonid A.
Rubakhin, Stanislav S.
Sweedler, Jonathan V.
ANALYTICAL CHEMISTRY, 2011, 83 (23) : 9181 - 9185
[23] Chemical mapping of the colorectal cancer microenvironment via MALDI imaging mass spectrometry (MALDI-MSI) reveals novel cancer-associated field effects
Mirnezami, R.
Spagou, K.
Vorkas, P. A.
Lewis, M. R.
Kinross, J.
Want, E.
Shion, H.
Goldin, R. D.
Darzi, A.
Takats, Z.
Holmes, E.
Cloarec, O.
Nicholson, J. K.
MOLECULAR ONCOLOGY, 2014, 8 (01): : 39 - 49
[24] MALDI imaging mass spectrometry in cancer research: Combining proteomic profiling and histological evaluation
Schoene, Cedrik
Hoefler, Heinz
Walch, Axel
CLINICAL BIOCHEMISTRY, 2013, 46 (06) : 539 - 545
[25] Heterogeneous tissue distributions of erlotinib in lung cancer using MALDI mass spectrometry imaging
Hayashi, Mitsuhiro
Tsubata, Yukari
Aikawa, Hiroaki
Tamura, Kenji
Fujiwara, Yasuhiro
Isobe, Takeshi
Hamada, Akinobu
CANCER SCIENCE, 2018, 109 : 902 - 902
[26] Identification of Differential N-Glycan Compositions in the Serum and Tissue of Colon Cancer Patients by Mass Spectrometry
Coura, Marcelo de M. A.
Barbosa, Eder A.
Brand, Guilherme D.
Bloch, Carlos, Jr.
de Sousa, Joao B.
BIOLOGY-BASEL, 2021, 10 (04):
[27] Recent Advances of MALDI-Mass Spectrometry Imaging in Cancer Research
Jung, Joohee
MASS SPECTROMETRY LETTERS, 2019, 10 (03) : 71 - 78
[28] MALDI mass spectrometry in prostate cancer biomarker discovery
Flatley, Brian
Malone, Peter
Cramer, Rainer
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS, 2014, 1844 (05): : 940 - 949
[29] Langartech: A Custom-Made MALDI Matrix Sprayer for MALDI Imaging Mass Spectrometry
Iloro, Ibon
Bueno, Amaia
Calvo, Javier
Urreta, Harkaitz
Elortza, Felix
JALA, 2016, 21 (02): : 260 - 267
[30] MALDI Imaging Mass Spectrometry of Neuropeptides in Parkinson's Disease
Hanrieder, Jorg
Ljungdahl, Anna
Andersson, Malin
JOVE-JOURNAL OF VISUALIZED EXPERIMENTS, 2012, (60):

← 1 2 3 4 5 →